(1)
Carlotta Scarpa; Vincenzo Vindigni; Franco Bassetto. The TLC-NOSF (Technology Lipido-Colloid Plus Nano-Oligo Saccharide Factor) Protease Inhibitor for the Treatment of Ulceration in Rheumatic Disease. Ann Ital Chir 2020, 9, 1-3.